Literature DB >> 7313320

Clinicopathological aspects of imidocarb dipropionate toxicity in horses.

L G Adams.   

Abstract

Six groups of four adult horses were twice injected intramuscularly at a 24 hour interval with 0, 2, 4, 8, 16 or 32 mg/kg of imidocarb dipropionate (IMDP) and monitored for 21 days. The LD50 of IMDP for 21 days after injection was two doses of 15.99 +/- 1.49 mg/kg with mortalities occurring within six days following the first injection. Increasing levels of IMDP were correlated with increasing rates of morbidity, mortality, local and systemic reactions, increasing levels of blood urea nitrogen, serum aspartate amino transferase, serum sorbitol dehydrogenase, serum creatine phosphokinase, neutrophilia and increasing severity of renal, hepatic and pulmonary lesions. Mortalities were attributed to acute renal cortical tubular necrosis and acute periportal hepatic necrosis induced by two injections of 16 or 32 mg/kg of IMDP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7313320

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

Review 1.  Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.

Authors:  Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo
Journal:  Exp Parasitol       Date:  2017-01-05       Impact factor: 2.011

2.  In vitro growth inhibition of Theileria equi by bumped kinase inhibitors.

Authors:  Fernanda Gimenez; Siddra A Hines; Ryan Evanoff; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Rama S R Vidadala; Robert H Mealey
Journal:  Vet Parasitol       Date:  2018-01-01       Impact factor: 2.738

3.  Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.

Authors:  O Nicolas Schwint; Massaro W Ueti; Guy H Palmer; Lowell S Kappmeyer; Melissa T Hines; R Timothy Cordes; Donald P Knowles; Glen A Scoles
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

4.  Development of a stable transgenic Theileria equi parasite expressing an enhanced green fluorescent protein/blasticidin S deaminase.

Authors:  Bumduuren Tuvshintulga; Arifin Budiman Nugraha; Tomoka Mizutani; Mingming Liu; Takahiro Ishizaki; Thillaiampalam Sivakumar; Xuenan Xuan; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

5.  Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.

Authors:  Massaro W Ueti; Robert H Mealey; Lowell S Kappmeyer; Stephen N White; Nancy Kumpula-McWhirter; Angela M Pelzel; Juanita F Grause; Thomas O Bunn; Andy Schwartz; Josie L Traub-Dargatz; Amy Hendrickson; Benjamin Espy; Alan J Guthrie; W Kent Fowler; Donald P Knowles
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

6.  Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi.

Authors:  Kelly Sears; Donald Knowles; Kelcey Dinkel; Philip W Mshelia; Cynthia Onzere; Marta Silva; Lindsay Fry
Journal:  Pathogens       Date:  2020-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.